Evidence map›Paper›PMID 41845553›Full record

ArticleJournal of pharmaceutical health care and sciences2026

Pharmaceutical needs at temporary dispensing sites in Suzu City during the subacute phase after the 2024 Noto Peninsula Earthquake: a cross-sectional study of disaster prescription trends.

Yukari Koike, Shuji Yamashita, Natsuki Umiji, Aina Kano, Aoi Koketsu, Yuka Nakasato, Momoka Yamashita, Nobuhiro Namaki, Masako Hashimoto, Akihiro Watanabe and 2 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yukari Koike *Laboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Shuji Yamashita *Laboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Natsuki UmijiLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Aina KanoLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Aoi KoketsuLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Yuka NakasatoLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Momoka YamashitaLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Nobuhiro NamakiLaboratory of Community Pharmacy, Gifu Pharmaceutical University, 1-25- 4 Daigaku-Nishi, Gifu, 501-1196, Japan.
Masako HashimotoIshikawa Pharmaceutical Association, 25-10 Hiromachi-i, Kanazawa, Ishikawa, 920-0032, Japan.
Akihiro WatanabeDepartment of Crisis Management Medicine, Hyogo Medical University, 1- 1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Taihei YamadaDepartment of Emergency, Disaster and Critical Care Medicine, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Hideki HayashiLaboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan. hayashih@gifu-pu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study examined pharmaceutical needs in the subacute phase following the 2024 Noto Peninsula Earthquake, using dispensed prescriptions as a proxy. We described demand patterns, the dispensing timeline amid early shortages, and the alignment between observed requirements and four disaster medicine lists.

methodsWe conducted a retrospective cross-sectional analysis of prescriptions dispensed in disaster-affected areas of Japan (primarily Suzu City) between January 7 and 13, 2024. A total of 236 prescriptions were included and categorized into major therapeutic classes. We separated regular prescriptions from as-needed (pro re nata, PRN) prescriptions. The dispensing interval was defined as the number of days from prescription issuance to dispensing. Coverage was calculated by comparing dispensed medicines against four disaster medicine lists, including the Japanese Medical Association Team (JMAT) Carry-on Medicine List.

resultsCardiovascular, central nervous system, and gastrointestinal drugs were the most commonly prescribed medicines. Early shortages delayed dispensing until wholesale supplies resumed on January 11. Regular and PRN prescriptions accounted for 41.9% and 53.8% of all prescriptions, respectively. However, PRN prescriptions were dispensed in fewer days. Coverage of the four disaster medicine lists ranged from 41.8% to 65.9%, with the highest coverage for the JMAT Carry-on Medicine List.

conclusionsThis study clarified the characteristics of pharmaceutical needs in Suzu City during the subacute phase, albeit within a limited scope based on the activities of specific medical support teams. Observed pharmaceutical requirements only partially overlapped with existing lists. Portable medicine lists, regional stockpiles, and local formularies tailored to community needs could improve responsiveness. Interim measures, such as temporary services and mobile support, helped bridge the gap in medicine access before supply chain recovery. In this setting, mobile pharmacy vehicles potentially played a central role until normal distribution resumed. These data can inform future disaster medicine planning.

Indexed as

2024 Noto Peninsula EarthquakeDisaster medicineEssential medicines listsMobile pharmacy vehiclePharmaceutical demand

Identifiers

PMID41845553
PMCPMC13112765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.